![George R. Marcellino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George R. Marcellino
Keine laufenden Positionen mehr
Karriereverlauf von George R. Marcellino
Ehemalige bekannte Positionen von George R. Marcellino
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IRIDEX CORPORATION | Direktor/Vorstandsmitglied | 31.12.2014 | 13.04.2018 |
Independent Dir/Board Member | 31.12.2014 | 01.10.2017 | |
Corporate Officer/Principal | 13.04.2018 | 10.02.2021 | |
Kedalion Therapeutics, Inc.
![]() Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01.01.2015 | 01.10.2017 |
OptiMedica Corp.
![]() OptiMedica Corp. Medical SpecialtiesHealth Technology OptiMedica Corp. manufactures medical devices. It is a ophthalmic device company dedicated to developing technologies that improve patient outcomes. It focuses in the cataract therapeutic area. The company was founded in 2004 and is headquartered in Sunnyvale, CA. | Gründer | 22.12.2010 | 01.01.2013 |
Corporate Officer/Principal | 01.01.2004 | 01.01.2013 | |
Coherent Medical Group
![]() Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Corporate Officer/Principal | 01.01.1993 | 01.01.2001 |
Lumenis, Inc.
![]() Lumenis, Inc. Medical DistributorsDistribution Services Lumenis, Inc. provides clinical solutions. Its products include M22, ResurFX, UltraPulse, Femtouch, AcuPulse, and LightSheer WAIRE. The firm also offers intense pulsed light, non ablative and diode lasers, acne scars treatment, blepharoplasty, laser hair removal, pigmentation, rosacea, scar revision, and tattoo removal. The company is headquartered in San Jose, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1993 | - |
Ausbildung von George R. Marcellino
City University of New York | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 4 |
Founder | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IRIDEX CORPORATION | Health Technology |
Private Unternehmen | 4 |
---|---|
OptiMedica Corp.
![]() OptiMedica Corp. Medical SpecialtiesHealth Technology OptiMedica Corp. manufactures medical devices. It is a ophthalmic device company dedicated to developing technologies that improve patient outcomes. It focuses in the cataract therapeutic area. The company was founded in 2004 and is headquartered in Sunnyvale, CA. | Health Technology |
Lumenis, Inc.
![]() Lumenis, Inc. Medical DistributorsDistribution Services Lumenis, Inc. provides clinical solutions. Its products include M22, ResurFX, UltraPulse, Femtouch, AcuPulse, and LightSheer WAIRE. The firm also offers intense pulsed light, non ablative and diode lasers, acne scars treatment, blepharoplasty, laser hair removal, pigmentation, rosacea, scar revision, and tattoo removal. The company is headquartered in San Jose, CA. | Distribution Services |
Coherent Medical Group
![]() Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Health Technology |
Kedalion Therapeutics, Inc.
![]() Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Health Technology |
- Börse
- Insiders
- George R. Marcellino
- Erfahrung